GENETIC-CONTROL OF HLA-A AND B-ANTIGENS IN SOMATIC-CELL HYBRIDS - REQUIREMENT FOR BETA-2 MICROGLOBULIN
GENETIC-CONTROL OF HLA-A AND B-ANTIGENS IN SOMATIC-CELL HYBRIDS - REQUIREMENT FOR BETA-2 MICROGLOBULIN
复制标题
DOI:
10.1111/j.1399-0039.1978.tb01233.x
复制
发表时间:
1978-01-01
期刊:
影响因子:
--
通讯作者:
BODMER, WF
中科院分区:
文献类型:
--
作者:
ARCEGOMEZ, B;JONES, EA;BODMER, WF
The [Burkitt''s lymphoma] cell line Daudi lacks HLA-A and HL-A-B antigens and .beta.2 microglobulin. Somatic cell hybrids derived from a fusion between this line and [sternal marrow] D98/AH-2 cells expressed 4 HLA antigens not detectable on either parent cell, i.e., A1, A10(Aw26), Bw16(Bw38) and Bw17. The initial definition by direct cytotoxicity assay was confirmed by absorption of reactions against target T [thymus-derived] lymphocytes, thus avoiding problems due to contaminating anti-Ia [immune response-associated antigen] antibodies, and by blocking the reactions by pretreatment with a chicken anti-human .beta.2 microglobulin serum. That the new specificities were due to the Daudi HLA region was confirmed by the finding that interspecific hybrids between Daudi and A9L, containing a single human chromosome 6, expressed A10 and Bw17. This also defined the haplotypes of Daudi as A10(Aw26), Bw17 and A1, Bw16(Bw38). The re-expression of the Daudi HLA-A and HL-A-B antigens in 2 independent sets of hybrids indicates that it does not carry a mutation in the HLA region. It was previously reported that somatic cell hybrids with Daudi, which contain chromosome 15, do not express human .beta.2 microglobulin. The reason for the lack of HLA-A and HL-A-B antigens on Daudi is probably a secondary effect due to the mutation(s) in the .beta.2 microglobulin gene.